Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Frauger

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Therapie|April 11, 2015
New methadone formulation in France: results from 5 years of utilizationQuentin Boucherie, Elisabeth Frauger, Xavier Thirion, et al.
Transplantation|January 25, 2003
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppressionPanayotis Lykavieris, Elisabeth Frauger, Dalila Habes, et al.
Therapie|June 11, 2019
[Improve the benefit/risk balance of methadone by respecting its pharmacological specificities]Elisabeth Frauger, Nathalie Fouilhé Sam-Laï, Michel Mallaret, et al.
Therapie|August 20, 2011
Evolution of opioids reimbursement since 2004 from the National Database of the General Health Insurance SystemVanessa Pauly, Vincent Pradel, Elisabeth Frauger, et al.
Therapie|November 8, 2024
Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM programClémence Lacroix, Elisabeth Frauger, Elisabeth Jouve, et al.
Fundamental & Clinical Pharmacology|September 2, 2016
Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM surveyAmélie Daveluy, Elisabeth Frauger, Hélène Peyrière, et al.
Therapie|April 11, 2015
Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidateJoëlle Micallef, Elisabeth Frauger, Aurore Palmaro, et al.
Therapie|May 22, 2022
[Increasing methylphenidate abuse: Tracking and profiles during 13-years]Clémence Guerra, Thomas Soeiro, Clémence Lacroix, et al.
Therapie|August 2, 2012
[National and regional market penetration rates of generic's high dosage buprenorphine: its evolution from 2006 to 2008, using reimbursed drug database]Christelle Boczek, Elisabeth Frauger, Joëlle Micallef, et al.
Fundamental & Clinical Pharmacology|March 21, 2013
OPPIDUM surveillance program: 20 years of information on drug abuse in FranceElisabeth Frauger, Christophe Moracchini, Reynald Le Boisselier, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Therapie|April 11, 2015
New methadone formulation in France: results from 5 years of utilizationQuentin Boucherie, Elisabeth Frauger, Xavier Thirion, et al.
Transplantation|January 25, 2003
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppressionPanayotis Lykavieris, Elisabeth Frauger, Dalila Habes, et al.
Therapie|June 11, 2019
[Improve the benefit/risk balance of methadone by respecting its pharmacological specificities]Elisabeth Frauger, Nathalie Fouilhé Sam-Laï, Michel Mallaret, et al.
Therapie|August 20, 2011
Evolution of opioids reimbursement since 2004 from the National Database of the General Health Insurance SystemVanessa Pauly, Vincent Pradel, Elisabeth Frauger, et al.
Therapie|November 8, 2024
Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM programClémence Lacroix, Elisabeth Frauger, Elisabeth Jouve, et al.
Fundamental & Clinical Pharmacology|September 2, 2016
Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM surveyAmélie Daveluy, Elisabeth Frauger, Hélène Peyrière, et al.
Therapie|April 11, 2015
Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidateJoëlle Micallef, Elisabeth Frauger, Aurore Palmaro, et al.
Therapie|May 22, 2022
[Increasing methylphenidate abuse: Tracking and profiles during 13-years]Clémence Guerra, Thomas Soeiro, Clémence Lacroix, et al.
Therapie|August 2, 2012
[National and regional market penetration rates of generic's high dosage buprenorphine: its evolution from 2006 to 2008, using reimbursed drug database]Christelle Boczek, Elisabeth Frauger, Joëlle Micallef, et al.
Fundamental & Clinical Pharmacology|March 21, 2013
OPPIDUM surveillance program: 20 years of information on drug abuse in FranceElisabeth Frauger, Christophe Moracchini, Reynald Le Boisselier, et al.
Pageof 6